GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $469,000 | +4.9% | 10,764 | +4.8% | 0.16% | +25.0% |
| Q1 2022 | $447,000 | -0.9% | 10,272 | +0.4% | 0.12% | +5.1% |
| Q4 2021 | $451,000 | +15.6% | 10,230 | +4.5% | 0.12% | -21.9% |
| Q2 2021 | $390,000 | +12.1% | 9,790 | +0.4% | 0.15% | +58.9% |
| Q1 2021 | $348,000 | -3.1% | 9,748 | +0.0% | 0.10% | -6.9% |
| Q4 2020 | $359,000 | -1.1% | 9,744 | +0.9% | 0.10% | -15.7% |
| Q3 2020 | $363,000 | -10.6% | 9,653 | -3.1% | 0.12% | -22.9% |
| Q2 2020 | $406,000 | +2.0% | 9,959 | -5.3% | 0.16% | -15.1% |
| Q1 2020 | $398,000 | -24.5% | 10,516 | -6.2% | 0.18% | +1.1% |
| Q4 2019 | $527,000 | +7.6% | 11,207 | -2.4% | 0.18% | +11.6% |
| Q3 2019 | $490,000 | +7.0% | 11,478 | +0.3% | 0.16% | -3.0% |
| Q2 2019 | $458,000 | -4.0% | 11,447 | +0.3% | 0.17% | -7.1% |
| Q1 2019 | $477,000 | +9.7% | 11,410 | +0.3% | 0.18% | -24.2% |
| Q4 2018 | $435,000 | – | 11,378 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |